APA (7th ed.) Citation

E, T., S, F., H, M., S, N., H, M., N, K., . . . H, H. (2026). Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(1), . https://doi.org/10.2807/1560-7917.ES.2026.31.1.2500336

Chicago Style (17th ed.) Citation

E, Takashita, et al. "Baloxavir Susceptibility of Seasonal Influenza Viruses During the First Seven Seasons of Clinical Use in Japan, 2017/18 to 2023/24." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 31, no. 1 (2026). https://doi.org/10.2807/1560-7917.ES.2026.31.1.2500336.

MLA (9th ed.) Citation

E, Takashita, et al. "Baloxavir Susceptibility of Seasonal Influenza Viruses During the First Seven Seasons of Clinical Use in Japan, 2017/18 to 2023/24." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 31, no. 1, 2026, https://doi.org/10.2807/1560-7917.ES.2026.31.1.2500336.